Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial
Completed · Phase 4
Conditions studied: Moderate-to-Severe Atopic Dermatitis, Atopic Eczema
In brief
The study is focused on skin of color participants who have moderate-to-severe atopic dermatitis. Atopic dermatitis, also referred to as eczema, is a condition that causes the skin to become itchy, dry, and cracked. From the previous studies on the study drug, it is seen that the study drug has an acceptable safety and effectiveness in participants with atopic dermatitis. The aim of this study is to get additional information on the safety and effectiveness of the study drug, particularly the information on aspects of atopic dermatitis in skin of color participants. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in your blood at different times * How much the study drug improves quality of life and mental health
Key facts
- Study ID
- NCT05590585
- Run by
- Regeneron Pharmaceuticals
- People needed
- 124
- Starts
- 2023-01-11
- Expected to finish
- 2024-11-14
- Last updated by the study team
- 2026-05-27
Who can join
Age: 12 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Total Skin & Beauty Dermatology Center — Birmingham, Alabama, United States
- The University Of Alabama At Birmingham — Birmingham, Alabama, United States
- C2 Research Center, LLC — Montgomery, Alabama, United States
- Center for Dermatology Clinical Research, inc. — Fremont, California, United States
- UCSD/ Rady Children's Hospital — San Diego, California, United States
- UCSF — San Francisco, California, United States
- SF Research Institute — San Francisco, California, United States
- University of Miami Miller School of Medicine — Miami, Florida, United States
- Skin and Cancer Associates, LLP — Miami, Florida, United States
- Century Research LLC — Miami, Florida, United States
- Advanced Medical Research PC — Atlanta, Georgia, United States
- Atlanta Biomedical Clinical Research LLC — Atlanta, Georgia, United States
- Northwestern Memorial Hospital — Chicago, Illinois, United States
- Callender Dermatology and Cosmetic Center — Glenn Dale, Maryland, United States
- Dermatology and Skin Cancer Specialists, LLC dba US Dermatology Partners — Rockville, Maryland, United States
- Wayne State University Physician Group Dermatology — Dearborn, Michigan, United States
- Revival Research Institute , LLC — Troy, Michigan, United States
- Washington University School of Medicine — St Louis, Missouri, United States
- Rao Dermatology — Atlantic Highlands, New Jersey, United States
- SUNY Downstate Medical Center — Brooklyn, New York, United States
- NYC Health + Hospital , Elmhurst Hospital Center — Elmhurst, New York, United States
- Markowitz Medical — New York, New York, United States
- Philip Fried, MD PLLC — The Bronx, New York, United States
- Duke University Medical Center — Durham, North Carolina, United States
- Oregon Health & Science University — Portland, Oregon, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.